Consistent with the in vitro functional experiments, the knockdown of ACP6 significantly increased both tumor burden and metastatic spread, while the overexpression of ACP6 reduced tumor burden and metastasis in both HeyA8 and Tyk-nu models (Fig. 4e and 4d–f). The gene discussed is ACP6; the disease is neoplasm.